Belgium· BE-AMP-SAM288434-00

Gardasil

A humaner papillomvirus (typen 6, 11, 16, 18) product containing human papillomavirus, types 6,11,16,18, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 8 of our 19 countries.

ATC J07BM01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedGardasilATCJ07BM01REGISTER NO.BE-AMP-SAM288434-00PACKS LISTED0CHECKEDSeptember 26, 2026

Where it is registered

Humaner papillomvirus (typen 6, 11, 16, 18) is registered in 8 of 19 countries.

Countries holding a registration under ATC J07BM01 (humaner papillomvirus (typen 6, 11, 16, 18)), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Humaner papillomvirus (typen 6, 11, 16, 18) · ATC J07BM01

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Papillomavirus, Types 6,11,16,18
Manufacturer
Merck Sharp & Dohme
Country
Belgium (BE)
ATC code
J07BM01
ATC class
Humaner Papillomvirus (Typen 6, 11, 16, 18)
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5fef9cf2-64e2-4efa-822c-3155b2f40a09
GET /v1/drugs/5fef9cf2-64e2-4efa-822c-3155b2f40a09?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Gardasil",
  "name_fr": "Gardasil",
  "name_nl": "Gardasil",
  "amp_code": "SAM288434-00",
  "strengths": null,
  "pack_count": 3,
  "substances": [
    "Human Papillomavirus, Types 6,11,16,18",
    "Borax",
    "Sodium Chloride",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Papillomavirus (human types 6, 11, 16, 18)",
  "authorisation_numbers": [
    "EU/1/06/357/001",
    "EU/1/06/357/002",
    "EU/1/06/357/018"
  ]
}

See everything about humaner papillomvirus (typen 6, 11, 16, 18).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.